Tremfya Induction Pack for Crohn's Disease

RxCUI: 2711638
RxNorm name: Tremfya Induction Pack for Crohn's Disease
Display name: Tremfya Induction Pack for Crohn's Disease
Full name: Tremfya Induction Pack for Crohn's Disease
Term type: SY
Status: DailyMed mapping
Updated: 2026-06-04 23:38:49

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLA	Proprietary name	Proper name	License type	Status	Latest source
761061	Tremfya	guselkumab	351(a)	Rx	2026-08-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
TREMFYA	GUSELKUMAB	Janssen Biotech, Inc.	1e6dc9ae-1c4c-42d9-87aa-c315ecc51b56	2026-06-04	Warnings, Adverse reactions	Exact identifier rxcui: 2711638

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
1e6dc9ae-1c4c-42d9-87aa-c315ecc51b56	{2 (2 ML guselkumab 100 MG/ML Auto-Injector [Tremfya]) } Pack [Tremfya Induction Pack for Crohn's Disease] [BPCK] · Tremfya Induction Pack for Crohn's Disease [PSN] · Tremfya Induction Pack for Crohn's Disease [SY]	3	28	These highlights do not include all the information needed to use TREMFYA safely and effectively. See full prescribing information for TREMFYA. TREMFYA ® (guselkumab) injection, for subcutaneous or intravenous use Initial U.S. Approval: 2017	20250929